ALBO

Albireo Pharma (ALBO)

Albireo Pharma Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ALBO

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/02/14	22:33	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:ALBO	Albireo Pharma Inc
2023/03/09	20:14	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:ALBO	Albireo Pharma Inc
2023/03/09	20:11	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:ALBO	Albireo Pharma Inc
2023/03/09	20:08	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:ALBO	Albireo Pharma Inc
2023/03/09	20:05	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:ALBO	Albireo Pharma Inc
2023/03/03	20:06	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALBO	Albireo Pharma Inc
2023/03/03	07:03	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALBO	Albireo Pharma Inc
2023/03/03	06:56	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALBO	Albireo Pharma Inc
2023/03/03	06:53	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALBO	Albireo Pharma Inc
2023/03/03	06:53	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:ALBO	Albireo Pharma Inc
2023/03/03	06:50	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:ALBO	Albireo Pharma Inc
2023/03/03	06:49	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:ALBO	Albireo Pharma Inc
2023/03/03	06:49	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:ALBO	Albireo Pharma Inc
2023/03/03	06:49	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:ALBO	Albireo Pharma Inc
2023/03/03	06:49	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALBO	Albireo Pharma Inc
2023/03/03	06:48	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:ALBO	Albireo Pharma Inc
2023/03/03	06:48	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:ALBO	Albireo Pharma Inc
2023/03/03	06:47	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:ALBO	Albireo Pharma Inc
2023/03/03	06:47	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:ALBO	Albireo Pharma Inc
2023/03/03	06:45	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:ALBO	Albireo Pharma Inc
2023/03/03	06:44	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALBO	Albireo Pharma Inc
2023/03/03	06:42	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALBO	Albireo Pharma Inc
2023/03/03	06:41	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALBO	Albireo Pharma Inc
2023/03/03	06:40	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALBO	Albireo Pharma Inc
2023/03/03	06:32	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:ALBO	Albireo Pharma Inc
2023/03/03	06:29	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ALBO	Albireo Pharma Inc
2023/03/03	01:29	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:ALBO	Albireo Pharma Inc
2023/03/03	01:24	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:ALBO	Albireo Pharma Inc
2023/02/28	06:06	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:ALBO	Albireo Pharma Inc
2023/02/25	07:29	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:ALBO	Albireo Pharma Inc